SCHEMBL6657698

SCHEMBL6657698

CC[C@@]1(C(=O)N2CCC(C(O)c3ccc(F)cc3)CC2)CCCCN1

nearest known ligand 0.47

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.47
CYP2D6 P10635 1/20 0.43
HTR2A P28223 5/20 0.43
HTR2C P28335 2/20 0.43
HTR7 P34969 2/20 0.43
HSD11B1 P28845 1/20 0.39
PARP1 P09874 2/20 0.39
HTR6 P50406 1/20 0.39
SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663655 0.82 HSD11B1 (0.51) HRH3HSD11B1
Hydrochloric Acid SCHEMBL6662530 0.81 HRH3 (0.52) HRH3PARP1
Hydrochloric Acid SCHEMBL6684984 0.79 CACNA2D1 (0.52) HRH3HTR7
Hydrochloric Acid SCHEMBL6656434 0.75 L3MBTL1 (0.50) HRH3
SCHEMBL6229667 0.71 HTR2A (0.56) CYP2D6HTR2AHTR2CHTR7HTR6
SCHEMBL27943832 0.70 HTR2A (0.55) CYP2D6HTR2AHTR2CHTR7HSD11B1
Hydrochloric Acid SCHEMBL6658313 0.70 PARP1 (0.38) HRH3CYP2D6HSD11B1PARP1SLC6A2
SCHEMBL6657235 0.70 HRH3 (0.44) HRH3PARP1
SCHEMBL6663012 0.69 HRH3 (0.55) HRH3PARP1
Hydrochloric Acid SCHEMBL7512052 0.69 CACNA2D1 (0.53) HRH3CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441728-A2 MODULATORS OF THE CHOLESTEROL BIOSYNTHETIC PATHWAY Vertex Pharmaceuticals Incorporated (US) 2004-08-04 EP disclosed
WO-2003037338-A2 MODULATORS OF THE CHOLESTEROL BIOSYNTHETIC PATHWAY VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-05-08 WO disclosed
EP-1257544-A2 PIPERAZINE AND PIPERIDINE DERIVATIVES FOR TREATMENT OR PREVENTION OF NEURONAL DAMAGE Vertex Pharmaceuticals Incorporated (US) 2002-11-20 EP disclosed
WO-2001058891-A2 PIPERAZINE AND PIPERIDINE DERIVATIVES FOR TREATMENT OR PREVENTION OF NEURONAL DAMAGE VERTEX PHARMACEUTICALS INCORPORATED (US) 2001-08-16 WO disclosed